We serve Chemical Name:3-benzyl-3-azabicyclo[3.3.1]nonan-9-one CAS:81879-64-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![3-benzyl-3-azabicyclo[3.3.1]nonan-9-one](https://a.dearchem.com/CAS2/81879-64-3.png)
Chemical Name:3-benzyl-3-azabicyclo[3.3.1]nonan-9-one
CAS.NO:81879-64-3
Synonyms:3-Azabicyclo[3.3.1]nonan-9-one,3-(phenylmethyl);3-benzyl-3-aza-bicyclo[3.2.1]nonan-9-one;N-Benzyl-3-azabicyclo[3.3.1]nonan-9-one;3-benzyl-3-aza-bicyclo[3.3.1]nonan-9-one
Molecular Formula:C15H19NO
Molecular Weight:229.31700
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:20.31000
Exact Mass:229.14700
LogP:2.42550
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Azabicyclo[3.3.1]nonan-9-one,3-(phenylmethyl) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-benzyl-3-aza-bicyclo[3.3.1]nonan-9-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Azabicyclo[3.3.1]nonan-9-one,3-(phenylmethyl) Use and application,3-benzyl-3-aza-bicyclo[3.2.1]nonan-9-one technical grade,usp/ep/jp grade.
Related News: With the closing of AstraZeneca’s mega $39 billion buyout of Alexion Pharmaceuticals this week, the U.K. pharma has officially picked up Soliris and its successor, Ultomiris. 2-[4-(methylsulfonyl)phenyl]-4-methylpyridine-N-oxide manufacturers BetterUp is appointing several behavioral scientists, engineers, account executives, marketers, and operations professionals in the region to accelerate product innovation tailored to the European market. The company’s total European headcount is expected to reach 150 in the next year, including representation in France, Benelux, and Sweden. 4-(benzo[1,3]dioxol-5-yl)-5-(6-methylpyridin-2-yl)-1,3-thiazol-2-amine suppliers The company will see an immediate $6 billion bump to its topline thanks to Alexion’s C5 inhibitors, used to treat rare diseases like paroxysmal nocturnal hemoglobinuria. (E)-1-(((S)-3,7-dimethyloct-6-en-1-yl)oxy)-3,7-dimethylocta-2,6-dien-1-ol vendor & factory.
